Vistagen Therapeutics, Inc. - Common Stock, par value $0.001 per share (VTGN)

CUSIP: 92840H400

Q2 2023 13F Holders as of 30 Jun 2023

Type / Class
Equity / Common Stock, par value $0.001 per share
Shares outstanding
39,040,476
Total 13F shares
966,706
Share change
+966,706
Total reported value
$1,807,113
Price per share
$1.87
Number of holders
30
Value change
+$1,807,113
Number of buys
30

Quarterly Holders Quick Answers

What is CUSIP 92840H400?
CUSIP 92840H400 identifies VTGN - Vistagen Therapeutics, Inc. - Common Stock, par value $0.001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Vistagen Therapeutics, Inc. - Common Stock, par value $0.001 per share (VTGN) as of Q2 2023

As of 30 Jun 2023, Vistagen Therapeutics, Inc. - Common Stock, par value $0.001 per share (VTGN) was held by 30 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 966,706 shares. The largest 10 holders included VANGUARD GROUP INC, GSA CAPITAL PARTNERS LLP, BlackRock Inc., MILLENNIUM MANAGEMENT LLC, GEODE CAPITAL MANAGEMENT, LLC, GOLDMAN SACHS GROUP INC, Y-Intercept (Hong Kong) Ltd, Cubist Systematic Strategies, LLC, RHUMBLINE ADVISERS, and STATE STREET CORP. This page lists 30 institutional shareholders reporting positions in this security for the Q2 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.